Metraipolis › archive › dc_d296244cba9e

Therapeutic synergies that overcome carboplatin resistance in triple-negative breast cancer — Europe PMC PMID:41630032

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41630032
DOI
10.1186/s13046-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-06T04:02:13.111Z
SHA-256 of the archived text
2282cf9a9aa467b972f772590388bd11494f3af899a2a44969b164cf8f671c99
Stable URL of this page
https://metraipolis.com/documento/dc_d296244cba9e

How to cite

Therapeutic synergies that overcome carboplatin resistance in triple-negative breast cancer — Europe PMC PMID:41630032 — Europe PMC (en), https://europepmc.org/article/MED/41630032 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d296244cba9e (Metraipolis archive dc_d296244cba9e, sha256 2282cf9a9aa467b972f772590388bd11494f3af899a2a44969b164cf8f671c99)
BibTeX
@misc{dcd296244cba9e,
  title = {Therapeutic synergies that overcome carboplatin resistance in triple-negative breast cancer — Europe PMC PMID:41630032},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41630032},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d296244cba9e; sha256 2282cf9a9aa467b972f772590388bd11494f3af899a2a44969b164cf8f671c99},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41630032. Agents can read the archived copy with the MCP tool read_document.